Pharmacology Antidepressant Agents Practice Test

Switching a patient from a selective serotonin reuptake inhibitor (SSRI) to a serotonin-norepinephrine reuptake inhibitor (SNRI) is often due to inadequate symptom relief with the SSRIs. SSRIs are typically the first-line treatment for depression, but not all patients respond satisfactorily to these medications. When a patient continues to experience depressive symptoms or does not achieve full remission on an SSRI, a healthcare provider might consider an SNRI because it not only influences serotonin levels but also norepinephrine, which can help target a broader range of depressive symptoms.

In cases where the SSRIs do not provide sufficient relief, SNRIs may enhance the therapeutic effects by utilizing multiple mechanisms of action, offering the potential for better efficacy in managing depression. This pathway is particularly important for clinicians to consider, as finding the right medication can significantly impact a patient’s quality of life.